Adverse analytical finding

An adverse analytical finding (AAF), also known as a testing positive, occurs when a laboratory accredited by the World Anti-Doping Agency (WADA) "identifies the presence of a prohibited substance and/or its metabolites or markers in a…

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

An adverse analytical finding (AAF), also known as a testing positive, occurs when a laboratory accredited by the World Anti-Doping Agency (WADA) "identifies the presence of a prohibited substance and/or its metabolites or markers in a sample". A related concept is the atypical finding (ATF) when the result is inconclusive, a category introduced in 2008.

Not all AAFs result in anti-doping sanctions; the rate varies by sport. In athletics, the rate of AAFs does not vary significantly by event and averages 0.95 percent of samples analyzed. However, sprinters were more likely to test positive for anabolic steroids while middle- and long-distance runners were more likely to test positive for peptides and growth factors.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1371048105 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001371048105 · captured 2026-08-24 · not yet sealed in the ledger · verify the chain · version history

Cite this page as: encyclopegia.org, “Adverse analytical finding”, snapshot enwiki-001371048105. https://encyclopegia.org/a/adverse-analytical-finding

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.